Therapies and procedures
Tachyarrhythmia management
Learn more about therapy options to treat tachyarrhythmia patients.
A defibrillator isn’t just a defibrillator.
Medtronic offers a full line of implantable cardioverter defibrillators (ICDs) and services for treating your patients with tachyarrhythmias. Our broad range of ICDs can provide individualized treatment utilizing ICD leads with proven reliability, and the nation’s leading remote monitoring platform.1
ICD systems
People are unique. Our ICD portfolio is too. Medtronic is revolutionizing defibrillation technology and delivering products and features to improve productivity, support clinic efficiency, and help manage patients’ tachyarrhythmias.
ICD features
The Medtronic ICD portfolio offers exclusive algorithms and device features like Intrinsic ATP™,2,3 SmartShock 2.0+,4 and TruAF™ technology.5,6 We’re focused on innovative tools to help you treat patients while avoiding preventable shocks and improving patients’ quality of life.7
Managing your patients
Our advanced therapies, monitoring solutions, and management services are designed to help your patients feel better, while improving the efficiency and effectiveness of care when treating tachyarrhythmias.7
Reduce complications
Reducing procedure-related complications is now more important than ever. Learn about the TYRX™ Absorbable Antibacterial Envelope, an innovative solution aimed to improve procedure-related outcomes.8
Medtronic Academy
Access interactive courses, videos and educational resources.
Follow us on social media
Stay up to date on product updates and events.
- LinkedIn: Cardiac & Vascular
- YouTube: Medtronic Europe
- Facebook: Medtronic EMEA
References
1
Devices supported on the CareLink network. January 2014. Data on file.
2
Swenson DJ, Taepke RT, Blauer JJE, et al. Direct comparison of a novel antitachycardia pacing algorithm against present methods using virtual patient modeling. Heart Rhythm. September 2020;17(9):1602-1608.
3
Arenal A, Proclemer A, Kloppe A, et al. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial. Europace. November 2016;18(11):1719-1725.
4
Auricchio A, Schloss EJ, Kurita T, et al. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. Heart Rhythm. May 2015;12(5):926-936.
5
Boriani G, et al. Understanding the incidence of AF in single-chamber ICD patients: a real-world analysis. Presented at Europace 2017.
6
Brown ML, et al. New AF Occurrence in Single-Chamber ICD Patients: Insights from a Real-World Investigation. Presented at HRS 2018.
7
Wathen MS, DeGroot PJ, Sweeney MO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. October 26, 2004;110(17):2591-2596.
8
Tarakji KG, Mittal S, Kennergren C, et al. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection. N Engl J Med. May 16, 2019;380(20):1895-1905.